NeuroSkin Spray - Itch / Neuroskin Itch-X
NeuroSkin Spray - Itch / Neuroskin Itch-X, NPN 80023649: natural health product licensed in Canada. Medicinal ingredients: DL-camphre.
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| DL-camphre | 1.9 % |
Non-medicinal ingredients
Essence de feuilles Melaleuca alternifolia, Eau, Huile de lavande, Ammonium Lauryl Sulfate, Éthanol, Phénoxyéthanol, Pétrolatum, Méthylcellulose, Carbonate de magnésium, Carbonate de calcium, Silice, Acide benzoïque, Acide Déshydroacétique, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | maximum: 2 years | Not specified | Not specified |
| Adultes et enfants | minimum: 2 years | 1 Pulvérisateur | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
For temporary relief of pain and/or itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites or minor skin irritations.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
For external use only. Keep out of reach of children. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Avoid contact with eyes and mucous membranes; if this happens, rinse thoroughly with water. If condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use and consult a healthcare practitioner. If overdose or accidental ingestion occurs, call Poison Control Centre immediately.
- Contra-Indications
Do not apply to wounds or damaged skin. Do not tightly bandage. Do not inhale (pump sprays, non-aerosols). Do not apply external heat, such as an electric heating pad, as this may result in excessive skin irritation or skin burn.
- Known Adverse Reactions
Rashes and/or burning have been known to occur; in which case discontinue use. Hypersensitivity such as allergy has been known to occur; in which case discontinue use.
Product record
- Licence holder
- AvVaa World Healthcare Products
- NPN or DIN-HM
- 80023649
- Status
- Inactive licence
- Licence date
- 7 February 2011
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Topique
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80023649
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “NeuroSkin Spray - Itch / Neuroskin Itch-X (AvVaa World Healthcare Products): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80023649-neuroskin-spray-itch-neuroskin-itch-x, updated 7 February 2011.